Rusfertide vs Semax
Overview
Rusfertide is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement.
This page compares Rusfertide and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Rusfertide | Semax | |
|---|---|---|
| Category | Weight Management & Metabolic | Cognitive Enhancement |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 19-108 mg | 300-600 mcg |
| Frequency | once weekly, subcutaneous | daily |
| Reported benefits | In the Phase 3 VERIFY trial, adding rusfertide to standard-of-care therapy allowed 76.9% of participants to achieve hematocrit control without phlebotomy during weeks 20-32, compared with 32.9% on placebo plus standard of care. Reported benefits are specific to polycythemia vera erythrocytosis management and have not been studied for other conditions. | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | Injection-site reactions (56%) and anemia (16%) were the most common adverse events in clinical trials; labeled warnings include thrombocytosis and embryo-fetal toxicity. | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. Rusfertide is categorised under Weight Management & Metabolic, while Semax falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Rusfertide: FDA-approved. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Rusfertide is typically dosed at 19-108 mg (once weekly, subcutaneous). Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Rusfertide and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Rusfertide and Semax?
- Rusfertide is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement. Rusfertide is FDA-approved for one or more indications, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Rusfertide used for?
- A once-weekly injectable hepcidin-mimetic peptide FDA-approved to treat erythrocytosis in adults with polycythemia vera.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take Rusfertide and Semax together?
- Some users combine peptides within a single protocol, but stacking Rusfertide and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Rusfertide or Semax FDA-approved?
- Rusfertide is FDA-approved for one or more indications. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Rusfertide — full monograph: mechanism, research, dosing & references
- Semax — full monograph: mechanism, research, dosing & references